tldrdailynews.com logo

Weight Loss Drug Zepbound Shows Promise for Treating Sleep Apnea

1 min read
Source: NBC News
Weight Loss Drug Zepbound Shows Promise for Treating Sleep Apnea
Photo: NBC News
TL;DR Summary

A new study suggests that the weight loss drug tirzepatide, found in Zepbound and Mounjaro, may also help treat severe sleep apnea by reducing the number of breathing interruptions during sleep. The research, funded by Eli Lilly and Co., showed significant improvements in patients' weight, blood pressure, and sleep quality. However, experts caution that more research is needed to confirm its effectiveness as a sole treatment for sleep apnea.

Topics:top-news#health#medical-research#obesity#sleep-apnea#tirzepatide#weight-loss
Share this article
  1. Weight loss drug Zepbound may help treat sleep apnea, improve blood pressure  NBC News
  2. Weight-Loss Drug Zepbound Offers a New Way to Treat Sleep Apnea  The New York Times
  3. Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds  Forbes
  4. Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year  CNBC
  5. Weight loss drug could ease sleep apnoea in people with obesity, study says  The Guardian

Reading Insights

Total Reads

0

Unique Readers

34

Time Saved

2 min

vs 3 min read

Condensed

88%

564 → 69 words

Want the full story? Read the original article

Read on NBC News